Introduction
Primary shunt hyperbilirubinaemia (PSH) is a rare cause of jaundice, characterized by an elevated unconjugated serum bilirubin level, increased urobilinogen excretion, hyperplastic ineffective erythropoiesis with a normal red cell survival, and occasionally anaemia. 1 Many of these features apply equally well to congenital dyserythropoietic anaemia (CDA), a syndrome in which prominent findings are ineffective erythropoiesis and dysplastic normoblasts in the bone marrow. Various subtypes have been described, based on morphological differences in these cells and antigenic alterations in the red cell membrane.2 Type I CDA is recognized by internuclear chromatin bridging and a disorganized chromatin pattern in the red cell precursors. Type II typically has numerous binucleate normoblasts, submembranous cisternae in the red cells and their precursors, best seen on electron microscopy, a positive Ham's test with a proportion of donor sera and a markedly increased expression of i antigen on the red cells. Type III presents as a moderate macrocytic anaemia, with giant multinucleate normoblasts in the bone marrow. Type IV and other atypical variants have also been recognized. 37 We report a patient who presented with mild jaundice and was found to have an unconjugated hyperbilirubinaemia and ineffective erythropoiesis. Anaemia was not initially present and dyserythropoiesis was mild, with none of the morphological features associated with CDA. His brother has similar clinical and haematological features, and a cousin has pyruvate kinase deficiency. In addition, two of his uncles have an ill-defined syndrome, associated with periodic attacks of mild jaundice, but blood samples were not available for study. No other family members were apparently abnormal.
Case report
The propositus is a 19 year old male from Mauritius who presented with a 4-year history of episodic nausea and abdominal discomfort. On examination the only abnormal physical finding was the presence of mild jaundice. The spleen was impalpable and ofnormal size on ultrasonography. Initial haematology showed the haemoglobin to be 14.7 g/dl, red cell count 4.36 x 1012/1, haematocrit 0.441/1, MCV 99.4 fl, MCH 33.6 pg, MCHC 33 g/dl, white cell count 4.2 x 109/1 and platelets 258 x 109/1. The reticulocyte index was 0.2%. The differential white cell count was normal and the red cells showed mild macrocytosis and occasional basophilic stippling. Subsequent blood counts have shown an essentially similar picture, with the haemoglobin dropping to 13.4 g/dl on one occasion.
The erythrocyte sedimentation rate was 5 mm in the first hour. Total and conjugated serum bilirubin was 60 and 6 pmol/l, respectively. Liver enzymes and serum lactic dehydrogenase were normal. Urine urobilinogen was positive on labstix screening and faecal urobilinogen was 1200 mg/100 g stool (normal range <200 mg/I00 g wet weight).
CLINICAL REPORTS 397
The serum haptoglobin was decreased. 2,3 DPG, glucose-6-phosphate dehydrogenase (G6PD), pyruvate kinase and 5' pyrimidine nucleotidase assays were all normal, as were the Ham's test and a full screen for abnormal haemoglobins. Bone marrow aspiration and trephine biopsy showed erythroid hyperplasia, with mild to moderate megaloblastic maturation; while occasional binucleate normoblasts were present, dyserythropoiesis was not a feature. Reticuloendothelial and normoblast iron was increased, but ring sideroblasts were absent. Ultrastructural studies of the marrow confirmed those findings seen on light microscopy. Red cell phenotyping showed no abnormalities of the I and i antigen.
Radionuclide studies, using standard methods,8 showed T50 51Cr to be 24 days (normal range 30 ± 4), with a calculated mean red cell lifespan of 92 days (normal range 120 ± 10). TI for 59Fe plasma clearance was 36 min (normal range 70-140), plasma iron turnover was 1.75 g Fe/ 100 ml blood/day (normal range 0.45-0.9) and red cell utilization was 45% at 14 days (normal >80%).
The family pedigree is shown in Figure 1 . Three of the patient's 4 siblings were tested. One brother (III-2) was normal, while the other had an unconjugated hyperbilirubinaemia and haematological features practically identical to that of the propositus. An older sister (III-4) was haematologically entirely normal, as were both parents. One of the patient's uncles was haematologically normal (II-5), while another had an obvious macrocytosis (II-4). Only one aunt was tested (II-6) and she was haematologically normal. Pyruvate kinase deficiency was documented in the propositus' cousin (III-1), but assays for pyruvate kinase in several first-degree relatives revealed normal values. 
Discussion
Shunt hyperbilirubinaemia describes the increase in bilirubin production associated with ineffective erythropoiesis, which is usually secondary to deficiencies offolate or vitamin B12, occurring also in thalassaemia and CDA. A rare primary variant has been described in a group of related young adults9 who were all mildly to moderately jaundiced, modestly anaemic with mild reticulocytosis, and all had palpable splenomegaly. Apart from occasional spherocytes the red cells were morphologically normal. The hyperplastic marrows were normoblastic and marked iron deposition in the Kupffer cells ofthe liver was noted in 2 patients. Radionuclide studies showed normal red cell survival but ineffective erythropoiesis. There have been 2 other reports of similar cases, in one of which there was also a family history of jaundice.10'11
Our patient is unusual in that the haemoglobin level was generally normal, whereas a moderate anaemia has characterized most other reported cases. The pattern of inheritance is obscure, since full family studies are not available, but jaundice in only the males suggests sex-linked transmission. Management has been reassurance of the patient and folate supplementation. However, the expanded body iron stores occurring without transfusion or iron, medication are cause for concern, since hepatic disease in similar conditions has been reported.'2 The pathogenesis is not clear, but has been attributed to increased plasma iron turnover.'3 The diagnosis of Gilbert's syndrome seems unlikely since there is a marked elevation of faecal urobilinogen levels. In Gilbert's syndrome this is either normal or reduced.'4 Although haematological abnormalities have been reported in Gilbert's syndrome, these have been demonstrated only by radionuclide studies, and anaemia and macrocytosis have not been a feature. '5 The pathogenesis of both PSH and CDA centres on markedly ineffective erythropoiesis. The precise defect at the cellular level remains obscure, although structural and transport defects of the membrane have been described.'6"'7 In view of the clinical, haematological and biochemical similarities, it would seem appropriate to regard both PSH and CDA syndromes as part of a single spectrum characterized by congenitally ineffective erythropoiesis.
